Key facts
- Notable investors include Marco Poel.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for SQ Innovation
- ·The full record, as it builds
Funding rounds
No funding rounds for SQ Innovation are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SQ Innovation
Manufacturer of Lasix ONYU, an FDA-approved combination product designed for the treatment of edema associated with heart failure. The company develops and commercializes therapeutic products that address cardiovascular conditions, enabling healthcare providers to improve treatment outcomes for patients with fluid retention disorders.
- Sector
- Healthcare
- HQ
- Burlington, MA, United States
- Founded
- 2019
- Employees
- 24
- Website
- sqinnovation.com/
- Ownership
- Privately Held (backing)
SQ Innovation doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SQ Innovation shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SQ Innovation in its N-PORT filings yet. We sweep new filings monthly.